# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Healthpeak Properties (NYSE:DOC) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0...
Mizuho analyst Omotayo Okusanya reinstates Healthpeak Properties (NYSE:DOC) with a Buy and announces $22 price target.
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target...
As of April 4, 2024, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as...
B of A Securities analyst Joshua Dennerlein upgrades Healthpeak Properties (NYSE:DOC) from Underperform to Buy and raises th...